-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.
-
Summary
-
Ligand Pharmaceuticals Inc quarterly Preferred Stock, Shares Issued history and growth rate from Q4 2010 to Q3 2024.
- Ligand Pharmaceuticals Inc Preferred Stock, Shares Issued for the quarter ending September 30, 2024 was 0 shares.